# Naturally Controlled Decongestion Using Renal Independent System in ADHF Patients, a European Registry

> **NCT06401109** · NA · NOT_YET_RECRUITING · sponsor: **AquaPass Medical Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Heart Failure
- Fluid Overload
- Acute Decompensated Heart Failure
- Edema

## Interventions

- **DEVICE:** AquaPass

## Key facts

- **NCT ID:** NCT06401109
- **Lead sponsor:** AquaPass Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2026-02
- **Final completion:** 2026-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06401109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06401109, "Naturally Controlled Decongestion Using Renal Independent System in ADHF Patients, a European Registry". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06401109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
